Plus Therapeutics, Inc.
PSTV
$0.26
$0.00-1.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -72.49% | -59.69% | -43.82% | -130.36% | 2.54% |
| Total Depreciation and Amortization | -48.97% | 10.02% | 33.22% | 38.08% | 38.85% |
| Total Amortization of Deferred Charges | -- | -140.00% | -121.98% | -111.43% | -100.00% |
| Total Other Non-Cash Items | 531.56% | 565.29% | 1,652.87% | 1,286.10% | -318.87% |
| Change in Net Operating Assets | -287.49% | -195.22% | -226.28% | 353.75% | 388.71% |
| Cash from Operations | -96.84% | -40.14% | -69.58% | -5.55% | 17.87% |
| Capital Expenditure | 54.11% | 72.88% | 79.77% | -5.83% | 8.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 79.39% | 107.55% | 74.93% | 66.05% | -- |
| Cash from Investing | 79.23% | 106.81% | 75.84% | 55.74% | -2,469.38% |
| Total Debt Issued | 36.33% | 13.55% | 13.55% | -- | -- |
| Total Debt Repaid | -75.05% | -59.05% | -45.73% | -558.52% | -148.51% |
| Issuance of Common Stock | 427.24% | 376.59% | 76.56% | 395.94% | 32.26% |
| Repurchase of Common Stock | -- | 100.00% | 91.00% | 91.00% | -232.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -3,125.68% | 55.47% | 100.00% | 100.00% |
| Cash from Financing | 389.91% | 386.18% | 85.88% | 790.07% | 79.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 202.41% | 223.34% | 55.22% | 170.92% | 11.37% |